DOCETERO RTU 120 MG INJECTION

Docetero RTU 120mg Injection is classified as an anticancer drug within the taxoid category. It contains the active ingredient Docetaxel, which is used to treat various types of cancer, including breast, prostate, non-small cell lung, stomach, and head and neck cancers. Cancer is characterized by the uncontrolled and abnormal proliferation of cells. This chemotherapy agent can be administered alone or in conjunction with other anticancer therapies.

Common side effects associated with Docetero RTU 120mg Injection may include dizziness, headaches, fever, infections, decreased appetite, sleep disturbances, joint or muscle pain, vision issues, weight loss, fatigue, dry mouth, lowered blood pressure, and hair loss, among others. If any of these side effects become bothersome or persist, please notify your doctor.

If you have an allergy to Docetero RTU 120mg Injection or any of its components, inform your doctor. Prior to starting this medication, it is essential to disclose any history of kidney or heart issues, vision problems, epilepsy, or alcohol dependency to your physician. This medication is contraindicated for individuals with severely low white blood cell counts or significant liver disease. Be sure to inform your healthcare provider about all medications you are currently taking, including supplements and herbal products, before beginning treatment with Docetero RTU 120mg Injection. It is also important to use effective contraception during treatment and for at least six months following the final dose.